Mga Batayang Estadistika
| LEI | 529900DHF2OCON457Y71 |
| CIK | 1656472 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cronos Group Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employ |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 7, 2025 |
Exhibit 99.1 Cronos Group Reports 2025 Second Quarter Results Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| June 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 4491 Concession Rd 12 Stayner, Ontario L0M 1S0 (Address of princi |
|
| June 2, 2025 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. References to “Cronos” in this report refer to Cronos Group Inc. and i |
|
| May 8, 2025 |
Exhibit 99.1 Cronos Group Reports 2025 First Quarter Results Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in total cash and cash equivalents and short-term investments TORONTO, May 8, 2025 - |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 8, 2025 |
Letter Agreement by and among Shannon Buggy, Cronos USA and the Company, dated May 6, 2025. Exhibit 10.3 May 6, 2025 Shannon Buggy At the Address on file with the Company Dear Shannon, This letter agreement (this “Letter Agreement”), effective as of May 6, 2025 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Senior Vice President, Global Head of People and Technology. Capitalized terms used in this Letter Agreement that are not |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 25, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| March 19, 2025 |
EXHIBIT 10.1 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - ANNA SHLIMAK (the “Executive”) - and - solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly owned subsidiary of Cronos Group; WHEREAS the Executive is currently employed by the Company pursuant to |
|
| March 19, 2025 |
EXHIBIT 10.2 March 19, 2025 James Holm At the Address on file with the Company Dear James, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your resignation from your employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware |
|
| March 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| February 27, 2025 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2024 Subsidiaries State or other jurisdiction of incorporation or organization Cronos Growing Company Inc. Canada Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. Israel Cronos Israel G.S. Pharmacy Ltd. Israel Cronos Isra |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 27, 2025 |
Exhibit 10.22 November 8, 2024 Mr. Jeffrey Jacobson At the Address on file with the Company Dear Jeff, Further to our recent discussions, this letter is to confirm that, effective as of October 24, 2024, the Base Salary, as defined in your amended and restated employment agreement with Cronos USA Client Services LLC and, solely for the purposes specified therein, Cronos Group Inc. and Hortican Inc |
|
| February 27, 2025 |
Exhibit 99.1 Cronos Group Reports 2024 Fourth Quarter and Full-Year Results Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million Spinach® Ends 2024 as the Number One Cannabis Brand in Canada1 PEACE NATURALS® Ends 2024 as the Number One Cannabis Brand in Israel 2 Industry leading balance sheet with $859 mil |
|
| February 27, 2025 |
Cronos Group Insider Trading Policy Exhibit 19.1 Insider Trading Policy Cronos Group Inc. Effective as of January 1, 2020 Version 2025A TABLE OF CONTENTS Section 1: Policy Overview 3 General Matters 4 Violations of Policy and Disciplinary Action 5 Scope 7 Section 2: Prohibited Conduct 9 Prohibition on Insider Trading 10 Prohibition Against Speculation, Hedging and Short-Selling 15 Prohibition on Pledging of Securities 16 No Standing |
|
| November 12, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| November 12, 2024 |
Certificate of Continuance and Articles of Cronos Group Inc. Exhibit 3.1 Number: C1256453 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time. ELECTRONIC CERTIFICATE Certificate of Continuation Number C1256453 ARTICLES OF Cronos Group Inc |
|
| November 12, 2024 |
Exhibit 99.1 Cronos Group Reports 2024 Third Quarter Results Net revenue in Q3 2024 increased by 38% year-over-year to $34.3 million Spinach® Becomes the Number One Cannabis Brand in Canada1 Industry-leading balance sheet with $862 million in cash and cash equivalents TORONTO, November 12, 2024 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2024 thir |
|
| November 12, 2024 |
Exhibit 10.1 August 23, 2024 Anna Shlimak At the Address on file with the Company Dear Anna, This letter agreement (this “Letter Agreement”), effective as of August 23, 2024 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Chief Strategy Officer. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 8, 2024 |
Certificate of Continuance and Articles of Cronos Group Inc. Exhibit 3.1 Number: C1256453 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time. ELECTRONIC CERTIFICATE Certificate of Continuation Number C1256453 ARTICLES OF Cronos Group Inc |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 8, 2024 |
Exhibit 99.1 Cronos Group Reports 2024 Second Quarter Results Net revenue in Q2 2024 increased by 46% year-over-year to $27.8 million Industry-leading balance sheet with $848 million in cash and cash equivalents Announced expansion of Cronos GrowCo designed to fuel global growth TORONTO, August 8, 2024 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2 |
|
| July 22, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employ |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 25, 2024 |
Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*** - Commercially Sensitive Information Redacted], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 20, 2024 among CRONOS GROWING COMPANY INC. as Borrower and THE LENDERS FROM TIM |
|
| June 25, 2024 |
Exhibit 10.2 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*** - Commercially Sensitive Information Redacted], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED SUPPLY AGREEMENT between CRONOS GROWING COMPANY INC. and PEACE NATURALS PROJECT INC. dated as of JUNE 20, 2024 AM |
|
| June 21, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 28, 2024 |
Cronos Terminates Sale-Leaseback of Peace Naturals Campus Cronos Terminates Sale-Leaseback of Peace Naturals Campus TORONTO, May 28, 2024 (GLOBE NEWSWIRE) – Cronos Group Inc. |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 15, 2024 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. References to “Cronos” in this report refer to Cronos Group Inc. and i |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (Address of |
|
| May 9, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 9, 2024 |
Exhibit 99.1 Cronos Group Reports 2024 First Quarter Results Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach® was top-3 in retail sales in Canada in the flower, edible, and vape categories in Q1 2024 Launched PEACE NATURALS® brand in the United Kingdom in May 2024 TORONTO, May 9, 2024 - Cr |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 26, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 25, 2024 |
CRON / Cronos Group Inc. / ALTRIA GROUP, INC. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Cronos Group Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 22717L101 (CUSIP Number) W. Hildebrandt Surgner, Jr. Vice President, Corporate Secretary and Associate General Counsel Altria Group, Inc. 6601 West Broa |
|
| April 25, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| April 25, 2024 |
EXECUTION VERSION 4855-8885-6758 v.7 VOTING AGREEMENT This VOTING AGREEMENT (this “Agreement”), dated as of April 24, 2024, is entered into by and between Cronos Group Inc., a corporation organized under the Laws of the Province of British Columbia, Canada (the “Company”), and Altria Group, Inc., a Virginia corporation (the “Shareholder” and, together with the Company, each a “Party” and collectiv |
|
| April 17, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2024 (April 11, 2024) CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commissio |
|
| April 17, 2024 |
Letter from KPMG LLP to the Securities and Exchange Commission dated April 16, 2024 KPMG LLP Vaughan Metropolitan Centre 100 New Park Place Suite 1400 Vaughan, ON, L4K 0J3 Telephone (905) 265-5900 Fax (905) 265-6390 www. |
|
| April 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| April 3, 2024 |
a240401gorelikemployment EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS ISRAEL G. |
|
| February 29, 2024 |
ce Naturals Project Inc. and Future Farmco Canada In Exhibit 10.31 WAIVER AND AMENDING AGREEMENT THIS AGREEMENT is made as of February 29, 2024, BETWEEN: PEACE NATURALS PROJECT INC. (the “Seller”) - and - FUTURE FARMCO CANADA INC. (the “Buyer”) RECITALS: A.Pursuant to an agreement of purchase and sale (commercial) dated as of November 26, 2023, between the Seller and the Buyer (as amended to the date hereof, collectively, the “Purchase Agreement”), |
|
| February 29, 2024 |
Exhibit 97.1 Restatement Compensation Recovery Policy Cronos Group Inc. Effective as of December 1, 2023 Department: Finance Policy Owner: Chief Financial Officer Policy Validator: Compensation Committee of the Board of Directors For updates or additions, please contact [email protected]. This document is uncontrolled when printed. For the current, official copy of this policy |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 29, 2024 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2023 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. |
|
| February 29, 2024 |
Exhibit 99.1 Cronos Group Reports 2023 Fourth Quarter and Full-Year Results1 Ended 2023 with approximately $862 million in cash and short-term investments Commenced sales to Australian partner Launched award-winning Lord Jones® brand in Canada Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022; on a constant currency basis consolidated net revenue increased 11% in Q4 2023 compare |
|
| February 29, 2024 |
Exhibit 10.24 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - JEFF JACOBSON (the “Executive”) - and - solely for the purposes specified herein, HORTICAN INC. (“Hortican”) - and - solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly owned subsidiary of Crono |
|
| February 29, 2024 |
Exhibit 10.30 AMENDING AGREEMENT THIS AGREEMENT is made as of February 8, 2024, BETWEEN: PEACE NATURALS PROJECT INC. (the “Seller”) - and - FUTURE FARMCO CANADA INC. (the “Buyer”) RECITALS: A.Pursuant to an agreement of purchase and sale (commercial) dated as of November 26, 2023, between the Seller and the Buyer (as amended to the date hereof, collectively, the “Purchase Agreement”), the Seller a |
|
| November 27, 2023 | ||
| November 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 27, 2023 |
Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility TORONTO, November 27, 2023 (GLOBE NEWSWIRE) – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that its wholly owned subsidiary entered into an agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), a vertical farming company, for the sale |
|
| November 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| November 8, 2023 |
Exhibit 99.1 Cronos Group Reports 2023 Third Quarter Results Industry-leading balance sheet with $840 million in cash and short-term investments Net revenue in Q3 2023 increased by 22% year-over-year to $24.8 million; on a constant currency basis, net revenue in Q3 2023 increased by 27% year-over-year to $26.0 million Spinach® was top-10 in retail sales in Canada in every category it's in - flower |
|
| August 8, 2023 |
Exhibit 99.1 Cronos Group Reports 2023 Second Quarter Results Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to streamline supply chain and improve cash flow Spinach® was top-10 in retail sales in every category it participates in - flower, edible, vape and pr |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| June 23, 2023 |
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders TORONTO, June 23, 2023 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023 (the “Meeting”), shareholders holding a total of 247,410,987 common shares of the Company voted in person or by proxy, represen |
|
| June 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 31, 2023 |
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow Plans to Exit Existing U. |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (Address of |
|
| May 31, 2023 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2022 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. References to “Cronos” in this report refer to Cronos Group In |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 9, 2023 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement") BETWEEN: HORTICAN INC. (the "Company") -and - Jeff Jacobson (the "Executive") -and - solely for the purposes specified herein, CRONOS GROUP INC. ("Cronos Group") WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to continue to engage the services of the Executive in a senior and specialized ca |
|
| May 9, 2023 |
ex991 Exhibit 99.1 Cronos Group Reports 2023 First Quarter Results Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a constant currency basis net revenue in Canada increased 14% in Q1 2023 compared to Q1 2022 Spinach® was top-10 in retail sales in the flower |
|
| April 28, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy St |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 28, 2023 |
ex991-cron4q22earningspr Cronos Group Reports 2022 Fourth Quarter and Full-Year Results Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021 Net revenue in Israel increased 128% in Full Year 2022 compared to Full Year 2021; on a constant currency basis net revenue in Israel increased 137% in Full Year 2022 compared to Full Year 2021 Ended 2022 with $878 million in cash and short-term investments Spinach® became the number one edible brand in Canada in January 2023 TORONTO, February 28, 2023 - Cronos Group Inc. |
|
| February 28, 2023 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2022 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 28, 2023 |
Letter Agreement by and between Anna Shlimak and Cronos USA Client Services LLC, dated February Exhibit 10.32 February 21, 2023 Anna Shlimak At the Address on file with the Company Dear Anna, Further to our recent discussions, this letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), confirms the following amendment to your employment agreement with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware |
|
| February 13, 2023 |
ex101-madoreletteragreem EXECUTION VERSION February 8, 2023 Robert Madore At the Address on file with the Company Dear Bob, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your separation from employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (the “Company”) and wholly owned subsidiary of Cronos Group Inc. |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commi |
|
| December 19, 2022 |
warrantlettercronos002 |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| December 19, 2022 |
CRON / Cronos Group Inc. / ALTRIA GROUP, INC. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Cronos Group Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 22717L101 (CUSIP Number) W. Hildebrandt Surgner, Jr. Vice President, Corporate Secretary and Associate General Counsel Altria Group, Inc. 6601 West Broa |
|
| December 19, 2022 |
EX-99.4 Exhibit 99.4 Altria Summit LLC 6601 West Broad Street Richmond, Virginia 23230 December 16, 2022 Cronos Group Inc. 720 King Street West Suite 320 Toronto, ON M5V 2T3 Attention: General Counsel Telephone: (416) 504-0004 Email: [email protected] Re: Abandonment of Warrant Issued by Cronos Group Inc. Dear Ladies and Gentlemen: Altria Summit LLC, the holder of a warrant to purchase 84,0 |
|
| November 14, 2022 |
ex101-holmemploymentagre EXECUTION VERSION EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - JAMES HOLM (the “Executive”) - and - solely for the purposes specified herein, CRONOS GROUP INC. |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| November 7, 2022 |
Exhibit 10.2 November 7, 2022 John Griese At the Address on file with the Company Dear John, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding the separation of your employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (“ |
|
| November 7, 2022 |
ex991toq3earnings8-k Cronos Group Reports 2022 Third Quarter Results Reported consolidated net revenue increased 3% year-over-year to $20. |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 7, 2022 |
Exhibit 10.1 November 7, 2022 Jeff Jacobson At the Address on file with the Company Dear Jeff, This letter agreement (this “Letter Agreement”), effective as of November 7, 2022 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Chief Growth Officer. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings |
|
| October 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| October 25, 2022 |
exhibit102 Ontario Commission des 22nd Floor 22e étage Securities valeurs mobilières 20 Queen Street West 20, rue queen ouest Commission de l’Ontario Toronto ON M5H 3S8 Toronto ON M5H 3S8 IN THE MATTER OF CRONOS GROUP INC. |
|
| October 25, 2022 |
exhibit101 UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION SECURITIES ACT OF 1933 Release No. |
|
| October 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| August 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 9, 2022 |
Exhibit 99.1 Cronos Group Reports 2022 Second Quarter Results Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022 Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022 Announced achievement of THCV equity milestone TORONTO, August 9, 2022 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos? or the ?Company?), today announces its 2022 se |
|
| June 24, 2022 |
Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders TORONTO, June 24, 2022 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos? or the ?Company?) announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the ?Meeting?) shareholders voting in person or by proxy held in total 265,763,587 common shares of the Company, representing 70.76% o |
|
| June 24, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 31, 2022 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2021 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. References to ?Cronos? in this report refer to Cronos Group In |
|
| May 31, 2022 |
SD 1 formsd123121.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ont |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 10, 2022 |
Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS ISRAEL G.S. CULTIVATION LTD. (No. 515790988) (the ?Company?) - and - RAN GORELIK, Israeli ID number 56789472, an individual residing in the City of Shilat, in Israel (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) WHEREAS the Company is an indirectly wholly-owned su |
|
| May 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 10, 2022 |
Exhibit 99.1 Cronos Group Reports 2022 First Quarter Results Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022 Israel net revenue increased by 263% year-over-year to $9.1 million in Q1 2022 Increased market share in Canada and Israel in Q1 2022 Mike Gorenstein returned as Chief Executive Officer TORONTO, May 10, 2022 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) |
|
| April 29, 2022 |
DEFA14A 1 a2022defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per |
|
| April 29, 2022 |
DEF 14A 1 a2022drafproxystatement.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use o |
|
| March 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| March 21, 2022 |
EXECUTION VERSION March 21, 2022 Kurt Schmidt At the Address on file with the Company Dear Kurt, This letter agreement (this ?Letter Agreement?), effective as of the date hereof (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding your retirement from employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (the ?Company?) and wholly owned subsidiary of Cronos Group Inc. |
|
| March 21, 2022 |
EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN: CRONOS USA CLIENT SERVICES LLC a limited liability company incorporated in the State of Delaware (the ?Company?) - and - MICHAEL GORENSTEIN an individual resident in Miami Beach, in the State of Florida (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. |
|
| March 21, 2022 |
Cronos Group Founder Mike Gorenstein Returns as CEO Kurt Schmidt, President and Chief Executive Officer, to Retire TORONTO, March 21, 2022 (GLOBE NEWSWIRE) ? Cronos Group Inc. |
|
| March 1, 2022 |
Exhibit 14.1 Code of Business Conduct and Ethics Cronos Group Inc. Effective as of November 1, 2018 Department: Legal Policy Owner: Xiuming Shum, General Counsel Policy Validator: Board of Directors of Cronos Group Inc. For updates or additions, please contact the Legal Department at [email protected] This document is uncontrolled when printed. For the current, official copy o |
|
| March 1, 2022 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2021 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Malta Holdings Limited Malta Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel |
|
| March 1, 2022 |
Exhibit 10.28 EXECUTION VERSION February 17, 2022 Anna Shlimak At the Address on file with the Company Dear Anna, This letter agreement (this ?Letter Agreement?), effective as of the date hereof (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding your position as Senior Vice President, Corporate Affairs. Capitalized terms used in this Letter Agreement that are no |
|
| March 1, 2022 |
Exhibit 10.27 EXECUTION VERSION EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) ?and - JOHN GRIESE (the ?Executive?) ?and - solely for the purposes specified herein, CRONOS GROUP INC. (the ?Cronos Group?) - and ? solely for the purposes specified herein, HORTICAN INC. (?Hortican?) WHEREAS the Company is a wholly-owned subsidiary of Cronos G |
|
| March 1, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| March 1, 2022 |
Description of Capital Stock of Cronos Group Inc. Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following description of the capital stock of Cronos Group Inc. (the ?Company,? ?we,? ?us,? and ?our?) is a summary and is not complete, may not contain all the information you should consider before investing in our capital stock and is qualified in its entirety by reference to, our Certificate of Continuation, Notice of Articles and Articles (the ?Art |
|
| March 1, 2022 |
Exhibit 99.1 Cronos Group Reports 2021 Fourth Quarter and Full-Year Results Consolidated net revenue increased 59% in Full Year 2021 compared to Full Year 2020 Announces the planned exit of its Peace Naturals Campus in Stayner, Ontario to streamline supply chain and improve profitability TORONTO, March 1, 2022 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group? or the ?Company?), today |
|
| February 18, 2022 |
NT 10-Q/A 1 cronos12b-251.htm NT 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25/A NOTIFICATION OF LATE FILING Commission File Number: 001-38403 CUSIP: 22717L1013 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Fo |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| February 18, 2022 |
Exhibit 99.1 Cronos Group Reports 2021 Third Quarter Results Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements Announces strategic realignment to support future growth strategies Consolidated net revenue increased 80% in the third quarter of 2021 compared to the third quarter of 2020 Launched Cronos Group's first cultured cannabinoid gummy and vape pr |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001- |
|
| February 18, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 30, 2021 |
Letter Agreement, dated as of November 26, 2021, between Hortican November 26, 2021 Xiuming Shum At the Address on file with the Company Dear Xiuming, This letter agreement (this ?Letter Agreement?), effective as of the date hereof (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding your resignation from your employment with Hortican Inc. |
|
| November 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 23, 2021 |
Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter TORONTO, Nov. |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-38403 CUSIP: 22717L1013 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| August 6, 2021 |
Exhibit 99.1 Cronos Group Reports 2021 Second Quarter Results Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach? launched new products in the edible, concentrate, and flower categories in Canada TORONTO, August 6, 2021 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (? |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 6, 2021 |
Exhibit 10.2 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) - and - TODD ABRAHAM (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) and solely for the purposes specified herein, HORTICAN INC. (?Hortican?) WHEREAS the Company is a wholly-owned subsidiary of Cronos Grou |
|
| August 6, 2021 |
Letter Agreement, dated as of August 6, 2021, between Hortican, Cronos Group and Jerry Barbato Exhibit 10.4 EXECUTION VERSION August 6, 2021 Jerry Barbato At the Address on file with the Company Dear Jerry, This letter agreement (this ?Letter Agreement?), effective as of August 9, 2021 (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding the separation of your employment with Hortican Inc., a corporation organized under the federal laws of Canada (the ?Comp |
|
| August 6, 2021 |
Exhibit 10.3 EXECUTION VERSION EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) - and - ROBERT MADORE (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in th |
|
| June 25, 2021 |
Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders Exhibit 99.1 Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders TORONTO, June 25, 2021 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group? or the ?Company?) announces that at its Annual Meeting of Shareholders held earlier today (the ?Meeting?) there were 430 shareholders voting in person or by proxy holding in total 280,023,803 common shares of the Company, repr |
|
| June 25, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 15, 2021 |
Exhibit 2.1 EXECUTION VERSION Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. OPTION PURCHASE AGREEMENT BY AND AMONG PHARMACANN INC., A DELAWARE CORPORATION, CRONOS USA HOLDINGS INC., A DELAWARE CORPORATION and upon execution of a joinder hereto, SUCH ADDITIONAL PURCHASERS Date |
|
| June 15, 2021 |
Exhibit 2.2 EXECUTION VERSION THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE. THE SECURITIES REPRESENTED HEREBY HAVE BEEN TAKEN BY THE REGISTERED OWNER FOR INVESTMENT, AND WITHOUT A VIEW TO RESALE OR DISTRIBUTION THEREOF, AND MAY NOT BE SOLD, TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT TO AN EF |
|
| June 15, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 14, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 14, 2021 |
Exhibit 99.1 Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast TORONTO and CHICAGO, June 14, 2021 ? Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group?) and |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 4, 2021 |
Exhibit 99.1 Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG BOSTON and TORONTO ? June 4, 2021 ? Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group?), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (?Ginkgo?), which is building the leading horizontal platform |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| June 4, 2021 |
Exhibit 10.1 Certain information, identified by brackets, has been excluded from the Amended and Restated Collaboration and License Agreement because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT between GINKGO BIOWORKS, INC. and CRONOS GROUP INC. TABLE OF CONTENTS Page 1. DEFINITIONS 5 2. COLLABO |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (Address of |
|
| June 1, 2021 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2020 Overview: Cronos Group Inc. is an innovative global cannabinoid company with international production and distribution across five continents. References to ?Cronos? in this report refer to Cronos Group Inc. and its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and in |
|
| May 7, 2021 |
EX-10.1 2 ex101.htm EX-10.1 Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: HORTICAN INC. (the “Company”) - and - TODD ABRAHAM (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company, through one or more of its wholly-owned subsidiaries, is in |
|
| May 7, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 7, 2021 |
Exhibit 99.1 Cronos Group Reports 2021 First Quarter Results Receives processing license for the commercial production and sale of cannabinoids using biosynthesis Announces plans to launch Spinach? branded edibles to the Canadian adult-use market Launches transformative Lord Jones? brand campaign entitled, "A Higher Order" Cronos Israel expands PEACE NATURALS? brand into the pre-roll category in t |
|
| May 7, 2021 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) - and - ANNA SHLIMAK (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in a senior and speciali |
|
| April 27, 2021 |
DEFA14A 1 noticeofinternet2021.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only |
|
| April 27, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| February 26, 2021 |
Cronos Group Inc. Code of Business Conduct and Ethics EX-14.1 3 a1411.htm EX-14.1 Exhibit 14.1 Code of Business Conduct and Ethics Cronos Group Inc. Effective as of November 1, 2018 Department: Legal Policy Owner: Xiuming Shum, General Counsel Policy Validator: Board of Directors of Cronos Group Inc. For updates or additions, please contact the Legal Department at [email protected] This document is uncontrolled when printed. For |
|
| February 26, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 26, 2021 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2020 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Malta Holdings Limited Malta Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 26, 2021 |
Description of Capital Stock of Cronos Group Inc. Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following description of the capital stock of Cronos Group Inc. (the ?Company,? ?we,? ?us,? and ?our?) is a summary and is not complete, may not contain all the information you should consider before investing in our capital stock and is qualified in its entirety by reference to, our Certificate of Continuation, Notice of Articles and Articles (the ?Art |
|
| February 26, 2021 |
Exhibit 99.1 Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Announces plans to launch Happy Dance™ in ULTA Beauty™ Cronos Israel continues to grow the PEACE NATURALS™ brand in the Israeli medical cannabis market Preserves robust balance sheet with approximately USD$1.3 billion in cash and short-term investments TORONTO, February 26, 2021 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRO |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| November 5, 2020 |
Exhibit 99.1 Cronos Group Reports 2020 Third Quarter Results Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD brand, Happy Dance™, in the U.S. market in partnership with Kristen Bell Cronos Israel received approval to sell PEACE NATURALS™ branded pre-rolls and oils in Israel Cronos Device Labs expands its cannabinoid research sc |
|
| November 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| September 9, 2020 |
Exhibit 99.1 Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO, September 9, 2020 – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that its Board of Directors has appointed Kurt Schmidt Presi |
|
| September 9, 2020 |
Exhibit 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT B E T W E E N: CRONOS USA CLIENT SERVICES LLC a limited liability company incorporated in the State of Delaware (hereinafter referred to as the “Company”) -and- MICHAEL GORENSTEIN, an individual resident in Miami Beach, in the State of Florida (hereinafter referred to as the “Executive”) -and- CRONOS GROUP INC., a corporation incorporated in B |
|
| September 9, 2020 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - KURT SCHMIDT (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in the position of Presi |
|
| September 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| August 6, 2020 |
Exhibit 99.1 Cronos Group Reports 2020 Second Quarter Results Cronos Israel commenced the sale of PEACE NATURALSTM products to the Israeli medical cannabis market Natuera completed three additional test exports of hemp-derived CBD extract to the U.S. for business development and R&D purposes Successfully implemented a new enterprise resource planning system across our Canadian business Appointed n |
|
| August 6, 2020 |
Exhibit 10.2 FORM OF CRONOS GROUP INC. RESTRICTED SHARE UNIT AGREEMENT This Restricted Share Unit Award Agreement (hereinafter referred to as the “Agreement”) is made and entered into this day of , 20 (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as “Cronos”) and [●] (hereinafter referred to as the “Grantee”), pursuant to the Cronos Group Inc. 2020 Omnibus Equity Inc |
|
| August 6, 2020 |
Exhibit 10.1 CRONOS GROUP INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN ARTICLE I GENERAL 1.1 Purpose The purpose of the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (as amended from time to time, the “Plan”) is to help Cronos Group Inc., a corporation formed under the Business Corporations Act (Ontario) (“Cronos”): (1) attract, retain and motivate key employees (including prospective employees) |
|
| August 6, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 6, 2020 |
Exhibit 10.3 FORM OF CRONOS GROUP INC. RESTRICTED SHARE UNIT AWARD AGREEMENT (Applicable for Israeli Grantees) This Restricted Share Unit Award Agreement (hereinafter referred to as the “Agreement”) is made and entered into this day of , 20 (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as “Cronos”) and [●] (hereinafter referred to as the “Grantee”), pursuant to the C |
|
| August 6, 2020 |
Exhibit 3.1 Number: C1256453 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time. ELECTRONIC CERTIFICATE This Notice of Articles was issued by the Registrar on: July 9, 2020 01: |
|
| July 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incor |
|
| July 20, 2020 |
Exhibit 10.1 EXECUTION VERSION CONFIDENTIAL July 20, 2020 Robert Rosenheck At the Address on file with the Company Dear Rob, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of your resignation of employment from Redwood Wellness, LLC, a Delaware limited liability company (the “Company”). Capitalized terms |
|
| July 9, 2020 |
Cronos Group Announces Completion of Continuance to British Columbia Exhibit 99.1 Cronos Group Announces Completion of Continuance to British Columbia TORONTO, July 9, 2020 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that, effective today, the Company has continued from the laws of the Province of Ontario to the laws of the Province of British Columbia (the “Continuance”).The Continuance was approved by shareholders of |
|
| July 9, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incorp |
|
| June 25, 2020 |
Cronos Group Inc. Announces Results of 2020 Annual and Special Meeting of Shareholders Exhibit 99.1 Cronos Group Inc. Announces Results of 2020 Annual and Special Meeting of Shareholders TORONTO, June 25, 2020 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual and Special Meeting of Shareholders held earlier today (the “Meeting”) there were 652 shareholders voting in person or by proxy holding in total 195,124,634 common sha |
|
| June 25, 2020 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incor |
|
| June 1, 2020 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2019 Overview: Cronos Group Inc. is an innovative global cannabinoid company with international production and distribution across five continents. References to “Cronos” in this report refer to Cronos Group Inc. and its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and in |
|
| June 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 720 King St. W., Suite 320 Toronto, Ontario M5V 2T3 (Address of principal |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 8, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2020 CRONOS GROUP INC. (Exact Name of Registrant as Specified in Charter) Ontario, Canada 001-38403 N/A (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 8, 2020 |
EXHIBIT 99.1 Cronos Group Reports 2020 First Quarter Results Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs Successfully completed first dried flower shipment to Israel, as Cronos Israel moves closer to entering the medical cannabis market with PEACE NATURALS™ branded products Natuera completes key operational milestones and begins test exports to the |
|
| April 28, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| April 6, 2020 |
CRON / Cronos Group Inc. PRE 14A - - PRE 14A PRE 14A 1 prelimproxystatement.htm PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of t |
|
| April 1, 2020 |
Cronos Group Inc. 2020 Omnibus Equity Incentive Plan. Exhibit 99.1 CRONOS GROUP INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN CRONOS GROUP INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN ARTICLE I GENERAL 1.1 Purpose The purpose of the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (as amended from time to time, the “Plan”) is to help Cronos Group Inc., a corporation formed under the Business Corporations Act (Ontario) (“Cronos”): (1) attract, retain and mot |
|
| April 1, 2020 |
CRON / Cronos Group Inc. S-8 - - S-8 As filed with the U.S. Securities and Exchange Commission on April 1, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada N/A (State or other jurisdiction of incorporation or organization) (IRS Employe |
|
| March 30, 2020 |
CRON / Cronos Group Inc. 6-K/A - Current Report of Foreign Issuer - 6-K/A ' UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2020 Commission File No. 001-38403 CRONOS GROUP INC. (Name of registrant) 720 King Street W., Suite 320 Toronto, Ontario M5V 2T3 (Address of registrant’s principal executive office) I |
|
| March 30, 2020 |
Exhibit 99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended March 31, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim f |
|
| March 30, 2020 |
CRON / Cronos Group Inc. 6-K/A - Current Report of Foreign Issuer - 6-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2020 Commission File No. 001-38403 CRONOS GROUP INC. (Name of registrant) 720 King Street W., Suite 320 Toronto, Ontario M5V 2T3 (Address of registrant’s principal executive office) Ind |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three Months Ended March 31, 2019 (in thousands of Canadian dollars) 1 NOTICE TO READER Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the s |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three and Nine Months Ended September 30, 2019 (in thousands of Canadian dollars) 1 Notice to reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31 |
|
| March 30, 2020 |
Exhibit 99.1 Cronos Group Reports 2019 Fourth Quarter and Full-Year Results Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids in partnership with Ginkg |
|
| March 30, 2020 |
Exhibit 99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended March 31, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim f |
|
| March 30, 2020 |
Notice to Reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six months ended June 30, 2019, and the three and nine months ended September 30, 2019, which were previously filed on SEDAR (the “interim financial statements”). Subsequent to the original issuance of the |
|
| March 30, 2020 |
CRON / Cronos Group Inc. 6-K/A - Current Report of Foreign Issuer - 6-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2020 Commission File No. 001-38403 CRONOS GROUP INC. (Name of registrant) 720 King Street W., Suite 320 Toronto, Ontario M5V 2T3 (Address of registrant’s principal executive office) Ind |
|
| March 30, 2020 |
Notice to Reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six months ended June 30, 2019, and the three and nine months ended September 30, 2019, which were previously filed on SEDAR (the “interim financial statements”). Subsequent to the original issuance of the |
|
| March 30, 2020 |
Exhibit 99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended June 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim fi |
|
| March 30, 2020 |
Exhibit 99.4 NOTICE TO READER As of June 30, 2019, Cronos Group Inc. (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchan |
|
| March 30, 2020 |
Exhibit 99.2 NOTICE TO READER As of June 30, 2019, Cronos Group Inc. (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchan |
|
| March 30, 2020 |
Exhibit 99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended September 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the inter |
|
| March 30, 2020 |
Exhibit 99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended June 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim fi |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three and Six Months Ended June 30, 2019 (in thousands of Canadian dollars) 1 Notice to reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019 |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Condensed Interim Unaudited Consolidated Financial Statements For the Three Months Ended March 31, 2019 and March 31, 2018 (In thousands of Canadian dollars) Notice to Reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six mont |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 30, 2020 CRONOS GROUP INC. (Exact Name of Registrant as Specified in Charter) Ontario, Canada 001-38403 N/A (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 30, 2020 |
Exhibit 99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended September 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the inter |
|
| March 30, 2020 |
The following items were the subject of a Form 12b-25 and are included herein: Items 6, 7, 7A, 8, 9A, 9B and Exhibits 23. |
|
| March 30, 2020 |
Exhibit 99.3 NOTICE TO READER As of June 30, 2019, Cronos Group Inc. (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchan |
|
| March 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada (State or other jurisdiction of incorporation) 001-38403 (Commission File Numbe |
|
| March 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada (State or other jurisdiction of incorporation) 001-38403 (Commission File Numbe |
|
| March 17, 2020 |
Cronos Group to Restate Certain 2019 Unaudited Interim Financial Statements Exhibit 99.1 Cronos Group to Restate Certain 2019 Unaudited Interim Financial Statements TORONTO, March 17, 2020 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced today that the Company determined, on the recommendation of the Audit Committee of the Company’s Board of Directors and after consultation with KPMG LLP, the Company’s independent |
|
| March 2, 2020 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2019 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Malta Holdings Limited Malta Cronos Device Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel C |
|
| March 2, 2020 |
Exhibit 10.10 EMPLOYMENT AGREEMENT THIS AGREEMENT is made and effective as of this 10th day of August, 2016 (the “Effective Date”). B E T W E E N : PHARMACAN CAPITAL CORPORATION, a corporation incorporated under the laws of Canada (hereinafter referred to as “PharmaCan” or the Corporation”) -and- MICHAEL GORENSTEIN, an individual resident in the City of New York, in the State of New York (hereinaf |
|
| March 2, 2020 |
Exhibit 10.20 SERVICE AGREEMENT This Service Agreement (this “Agreement”) is entered into as of October 1, 2015 (the “Effective Date”), by and between The Peace Naturals Project Inc. (the “Company”), and Hillhurst Management Inc. (the “Vendor”). The Company and the Vendor are collectively referred to herein as the “Parties.” RECITAL WHEREAS, the Vendor has specialized financial skills, experience |
|
| March 2, 2020 |
Exhibit 10.19 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: HORTICAN INC. (the “Company”) - and - William Lawrence Hilson (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in a senior and specialized c |
|
| March 2, 2020 |
Exhibit 10.23 November 15, 2019 William Hilson c/o Cronos Group Dear Billy: This letter confirms our recent discussions. As we advised, your employment with Hortican Inc. (the “Company”) will terminate on a without cause basis effective as of close of business on December 31, 2019 (the “Separation Date”). The Company will pay you all outstanding salary and accrued but unused vacation pay owing up |
|
| March 2, 2020 |
Cronos Group Inc. Code of Business Conduct and Ethics. Exhibit 14.1 Code of Business Conduct and Ethics Cronos Group Inc. Effective as of November 1, 2018 Department: Legal Policy Owner: Xiuming Shum, General Counsel Policy Validator: Board of Directors of Cronos Group Inc. For updates or additions, please contact the Legal Department at [email protected] This document is uncontrolled when printed. For the current, official copy o |
|
| March 2, 2020 |
Exhibit 4.1 1 2 |
|
| March 2, 2020 |
Cronos Group Inc. Employment Inducement Award Plan #1. Exhibit 10.21 CRONOS GROUP INC. EMPLOYMENT INDUCEMENT AWARD PLAN #1 1.INTERPRETATION: As used in the Plan, the following terms shall have the meanings set forth below. To the extent any such term is defined in an applicable Award Agreement, the definition in such Award Agreement shall control. (a) “Affiliate” means any entity directly or indirectly controlling, controlled by or under common contro |
|
| March 2, 2020 |
Exhibit 10.14 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: HORTICAN INC. (the “Company”) - and - Xiuming Shum (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to continue to engage the services of the Executive in a senior and specialized |
|
| March 2, 2020 |
Exhibit 10.11 DESCRIPTION OF ORAL AMENDMENT TO EMPLOYMENT AGREEMENT Cronos Group Inc., f/k/a Pharmacan Capital Corporation (“Cronos”), and Michael Gorenstein (“Executive”) orally agreed to amend the Employment Agreement between Cronos and Executive dated as of August 10, 2016 (the “Employment Agreement”) to increase the Base Salary (as defined in the Employment Agreement) from USD200,000.00 to CAD |
|
| March 2, 2020 |
CRON / Cronos Group Inc. 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| March 2, 2020 |
Exhibit 10.16 CRONOS GROUP INC. RESTRICTED SHARE UNIT AGREEMENT This Restricted Share Unit Agreement (hereinafter referred to as the “Agreement”) is made and entered into this 5th day of September, 2019 (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as the “Company”) and Robert Rosenheck (hereinafter referred to as the “Participant”), pursuant to the Cronos Group Inc. |
|
| March 2, 2020 |
Exhibit 10.17 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: HORTICAN INC. (the “Company”) - and - DAVID HSU (the “Executive”) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group Inc. (“Cronos Group”); WHEREAS the Company wishes to engage the services of the Executive in a senior and specialized capacity and the Executive will have extensive access to the customers, vendor |
|
| March 2, 2020 |
Exhibit 10.22 November 15, 2019 David Hsu c/o Cronos Group Dear David: This letter confirms our recent discussions. As we advised, your employment with Hortican Inc. (the “Company”) will terminate on a without cause basis effective as of close of business on December 31, 2019 (the “Separation Date”). The Company will pay you all outstanding salary and accrued but unused vacation pay owing up to th |
|
| March 2, 2020 |
Exhibit 10.24 Indemnity Agreement This Indemnity Agreement (this “Agreement”) is made as of the [ ] day of [ ], 20[ ], between Cronos Group Inc., a body corporate incorporated under the laws of Ontario (the “Corporation”), and [ ] (the “Indemnified Party”), an individual resident in the [Province/State] of [●]. RECITALS: A. The Indemnified Party is or was a director and/or an officer of the Corpor |
|
| March 2, 2020 |
Exhibit 10.4 FIRST AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT This First Amendment to the Collaboration and License Agreement (this “First Amendment”) is entered into as of May 9, 2019 (the “First Amendment Effective Date”), by and between Ginkgo Bioworks, Inc., a corporation duly organized and existing under the laws of the State of Delaware, U.S.A., having a place of business at 27 Drydock |
|
| March 2, 2020 |
Exhibit 10.7 CRONOS GROUP INC. FIRST AMENDMENT TO THE AMENDED AND RESTATED STOCK OPTION PLAN THIS FIRST AMENDMENT (the “First Amendment”) amending Cronos Group Inc.’s Amended and Restated Stock Option Plan (the “Plan”) shall be effective as of August 7, 2019. WHEREAS the Company wishes to amend the Plan to add a new Schedule B as set forth herein (the “Amendments”); AND WHEREAS the Board is permit |
|
| March 2, 2020 |
Description of Capital Stock of Cronos Group Inc. Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following description of the capital stock of Cronos Group Inc. (the “Company,” “we,” “us,” and “our”) is a summary and is not complete, may not contain all the information you should consider before investing in our capital stock and is qualified in its entirety by reference to, our Certificate of Incorporation and Articles of Incorporation (including |
|
| March 2, 2020 |
CRON / Cronos Group Inc. NT 10-K - - NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-38403 CUSIP: 22717L1013 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ |
|
| March 2, 2020 |
Exhibit 10.13 EMPLOYMENT AGREEMENT BETWEEN: HORTICAN INC. (the “Company”) -and- XIUMING SHUM (the “Employee”) WHEREAS the Company and the Employee have agreed that the Employee shall be employed by the Company under the terms and conditions set out herein; In consideration of the respective covenants and agreements herein contained and for other good and valuable consideration, the receipt and suf |
